Publikationen, an denen er mitarbeitet Ricardo Astorga Jimenez (11)

2006

  1. Efficacy of lanreotide Autogel® administered every 4-8 weeks in patients with acromegaly previously responsive to lanreotide microparticles 30 mg: A phase III trial

    Clinical Endocrinology, Vol. 65, Núm. 3, pp. 320-326

2003

  1. Preoperative lanreotide treatment for GH-secreting pituitary adenomas: Effect on tumour volume and predictive factors of significant tumour shrinkage

    Clinical Endocrinology, Vol. 58, Núm. 4, pp. 471-481

1999

  1. Regulation of growth hormone secretion by signals produced by the adipose tissue

    Journal of Endocrinological Investigation, Vol. 22, Núm. 5 SUPPL., pp. 22-26

  2. The growth hormone (GH)-releasing hormone - GH - insulin-like growth factor-1 axis in patients with fibromyalgia syndrome

    Journal of Clinical Endocrinology and Metabolism, Vol. 84, Núm. 9, pp. 3378-3381

1998

  1. Enhanced growth hormone (GH) responsiveness to GH-releasing hormone after dietary restriction in patients with Cushing's syndrome

    Clinical Endocrinology, Vol. 48, Núm. 1, pp. 117-121

  2. Serum leptin levels in male marathon athletes before and after the marathon run

    Journal of Clinical Endocrinology and Metabolism, Vol. 83, Núm. 7, pp. 2376-2379

1997

  1. Acute pharmacological reduction of plasma free fatty acids enhances the growth hormone (GH)-releasing hormone-mediated GH secretion in patients with Cushing's syndrome

    Journal of Clinical Endocrinology and Metabolism, Vol. 82, Núm. 9, pp. 3165-3168

1996

  1. Serum immunoreactive-leptin levels are increased in patients with Cushing's syndrome

    Hormone and Metabolic Research, Vol. 28, Núm. 12, pp. 711-713

1995

  1. Growth hormone (GH) responses to the combined administration of GH-releasing hormone plus GH-releasing peptide 6 in adults with GH deficiency

    European Journal of Endocrinology, Vol. 132, Núm. 6, pp. 712-715

1993

  1. Growth hormone releasing hormone priming increases growth hormone secretion in patients with Cushing's syndrome

    Clinical Endocrinology, Vol. 38, Núm. 4, pp. 399-403

1990

  1. EFFECT OF ENHANCEMENT OF ENDOGENOUS CHOLINERGIC TONE WITH PYRIDOSTIGMINE ON GROWTH HORMONE (GH) RESPONSES TO GH‐RELEASING HORMONE IN PATIENTS WITH CUSHING'S SYNDROME

    Clinical Endocrinology, Vol. 33, Núm. 2, pp. 291-295